1. ISLHD Health Libraries
  2. ISLHD Health Libraries
  3. Research publications from current and former ISLHD staff.
Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/6280
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEssink BJen
dc.contributor.authorShapiro Cen
dc.contributor.authorIsidro MGDen
dc.contributor.authorBradley Pen
dc.contributor.authorPragalos Aen
dc.contributor.authorBloch Men
dc.contributor.authorSantiaguel Jen
dc.contributor.authorFrias MVen
dc.contributor.authorMiyakis Sen
dc.contributor.authorAlves de Mesquita Men
dc.contributor.authorBerrè S, Servais Cen
dc.contributor.authorWaugh Nen
dc.contributor.authorHoffmann C, Baba Een
dc.contributor.authorSchönborn-Kellenberger Oen
dc.contributor.authorWolz OOen
dc.contributor.authorKoch SDen
dc.contributor.authorGanyani Ten
dc.contributor.authorBoutet Pen
dc.contributor.authorMann Pen
dc.contributor.authorMueller SOen
dc.contributor.authorRamanathan Ren
dc.contributor.authorGaudinski MRen
dc.contributor.authorVanhoutte Nen
dc.date.accessioned2024-10-31T01:07:01Z-
dc.date.available2024-10-31T01:07:01Z-
dc.date.issued2024-10-31-
dc.identifier.citationHum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18.en
dc.identifier.urihttps://islhd.intersearch.com.au/islhdjspui/handle/1/6280-
dc.subjectVaccine-
dc.subjectCovid 19-
dc.titleSafety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation studyen
dc.identifier.journaltitleHum Vaccin Immunotheren
dc.identifier.doi10.1080/21645515.2024.2408863en
dc.contributor.islhdMiyakis, Spirosen
Appears in Collections:Research publications from current and former ISLHD staff.

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.